✦ LIBER ✦

Lipid-Altering Therapies and the Progression of Atherosclerotic Disease

✍ Scribed by Anthony S. Wierzbicki

Book ID: 105984680
Publisher: Springer
Year: 2007
Tongue: English
Weight: 126 KB
Volume: 30
Category: Article
ISSN: 1432-086X
DOI: 10.1007/s00270-006-0183-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Altering disease progression: the key to

Altering disease progression: the key to successful patient management

✍ J. Nordling 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Role of Toll-like receptor 4 in the init

Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease

✍ G. Pasterkamp; J. K. Van Keulen; D. P. V. De Kleijn 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

Review article: altering the natural his

Review article: altering the natural history of Crohn's disease – evidence for and against current therapies

✍ S. VERMEIRE; G. VAN ASSCHE; P. RUTGEERTS 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 546 KB

The Evolution and Role of Endovascular T

The Evolution and Role of Endovascular Therapy for the Treatment of Intracranial Atherosclerotic Disease

✍ Peter A. Rasmussen; on behalf of the US Wingspan Registry Group 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Strategies to alter the progression of A

Strategies to alter the progression of Alzheimer's disease

✍ Robert Siman; Richard W. Scott 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 670 KB

Recent advances in the genetics of familial Alzheimer's disease provide direction for therapeutic strategies to alter the progressive neurodegeneration. The rationale is particularly strong for targeting the deposition of amyloid into neuritic plaques, but attention has also turned to abnormalities

Antihypertensive therapy and progression

Antihypertensive therapy and progression of chronic renal disease

✍ Lance D. Dworkin; Douglas G. Shemin 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 287 KB